Self-reported burden of caregiver of adults with depression: a cross-sectional study in five Western European countries
Balkaran, B. L, Jaffe, D. H, Umuhire, D, Rive, B, Milz, R. U
Published in BMC psychiatry (21.06.2021)
Published in BMC psychiatry (21.06.2021)
Get full text
Journal Article
Esketamine nasal spray shows higher remission and response rates over 32 weeks of treatment compared with quetiapine extended-release in patients with treatment resistant depression: Results from ESCAPE-TRD, a randomised, phase IIIb clinical trial
Reif, A, A E Anıl Yağcıoğlu, Luts, A, Messer, T, Nielsen, R, Buyze, J, Ito, T, Kambarov, Y, S Mulhern Haughey, Rive, B, Usankova, I, C von Holt, Godinov, Y
Published in European psychiatry (01.03.2023)
Published in European psychiatry (01.03.2023)
Get full text
Journal Article
Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression
Young, A H, Baune, B T, Cardoner, N, Frey, R, Ito, T, Kambarov, Y, Lacerda, A, Rive, B, C von Holt, Oliveira-Maia, A J
Published in European psychiatry (01.08.2024)
Published in European psychiatry (01.08.2024)
Get full text
Journal Article
Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization
Heerlein, K., De Giorgi, S., Degraeve, G., Frodl, T., Hagedoorn, W., Oliveira-Maia, A.J., Otte, C., Perez Sola, V., Rathod, S., Rosso, G., Sierra, P., Vita, A., Morrens, J., Rive, B., Mulhern Haughey, S., Kambarov, Y., Young, A.H.
Published in Journal of affective disorders (01.02.2022)
Published in Journal of affective disorders (01.02.2022)
Get full text
Journal Article
Esketamine Nasal Spray Improves Rate and Time to Remission Versus Quetiapine Extended Release in Subgroups of Patients With Treatment Resistant Depression and Two or Three Plus Prior Treatment Failures: Results From ESCAPE-TRD, a Randomised Phase IIIb Trial
Young, A.H., Cubała, W.J., Nielsen, R.E., Popova, A., Ito, T., Mulhern-Haughey, S., Pirotte, N., Rive, B., Thilakarathne, P., Usankova, I., Godinov, Y.
Published in BJPsych open (01.07.2023)
Published in BJPsych open (01.07.2023)
Get full text
Journal Article
Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway
Rive, B., Aarsland, D., Grishchenko, M., Cochran, J., Lamure, M., Toumi, M.
Published in International journal of geriatric psychiatry (01.06.2012)
Published in International journal of geriatric psychiatry (01.06.2012)
Get full text
Journal Article
P.2.f.005 Vortioxetine effects on overall patient functioning in patients with major depressive disorder
Florea, I, Loft, H, Danchenko, N, Rive, B, Brignone, M, Merikle, E, Sheehan, D.V, Jacobsen, P.L
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
Relative Efficacy and Tolerability of Vortioxetine versus Approved Antidepressants for Major depressive Disorder: a meta-regression of Clinical Trials
Diamand, F, Danchenko, N, Brignone, M, Rive, B, Perez, V, Ereshefsky, L, Francois, C, Merikle, E
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
P.2.b.048 Functional impairment in major depressive disorder: preliminary findings of the PERFORM study
Saragoussi, D, Haro, J.M, Boulenger, J.P, Lamy, F.X, Di Nicola, S, Rive, B
Published in European neuropsychopharmacology (01.10.2013)
Published in European neuropsychopharmacology (01.10.2013)
Get full text
Journal Article
History of Antidepressant use Among Primary Care Depressed Patients Switching Treatments in the United Kingdom
Lamy, F.X, Quelen, C, Brignone, M, Ferchichi, S, Vataire, A.L, Rive, B, Saragoussi, D
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)
Lam, R.W, Saragoussi, D, Danchenko, N, Rive, B, Lamy, F.X, Brevig, T
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants
Llorca, P.M, Lançon, C, Brignone, M, Rive, B, Salah, S, François, C
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
The effect of vortioxetine (LU AA21004) on health-related quality of life (HRQOL) in patients with major depressive disorder (MDD)
Florea, I, Danchenko, N, Loft, H, Rive, B, Pendlebury, S, Abetz, L
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article
PMH6 Evolution of Antidepressant Efficacy Over Time: Illustration With Escitalopram
Llorca, P.M, Lançon, C, Brignone, M, Rive, B, Painchault, C, Bent-Ennakhil, N, François, C
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
Cost effectiveness of memantine in Alzheimer's disease in the UK
Rive, B, Grishchenko, M, Guilhaume-Goulant, C, Katona, C, Livingston, G, Lamure, M, Toumi, M, François, C
Published in Journal of medical economics (14.07.2010)
Published in Journal of medical economics (14.07.2010)
Get more information
Journal Article